These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8377385)

  • 1. Nitric oxide mediates renal vasodilation during erythropoietin-induced polycythemia.
    Wilcox CS; Deng X; Doll AH; Snellen H; Welch WJ
    Kidney Int; 1993 Aug; 44(2):430-5. PubMed ID: 8377385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide influences blood flow distribution in renovascular hypertension.
    Sigmon DH; Beierwaltes WH
    Hypertension; 1994 Jan; 23(1 Suppl):I34-9. PubMed ID: 8282373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation.
    Casadevall M; Piqué JM; Cirera I; Goldin E; Elizalde I; Panés J; Martínez-Cuesta MA; Bosch J; Terés J; Rodés J
    Gastroenterology; 1996 Apr; 110(4):1156-65. PubMed ID: 8613005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vasodilation with L-arginine. Effects of dietary salt.
    Deng X; Welch WJ; Wilcox CS
    Hypertension; 1995 Aug; 26(2):256-62. PubMed ID: 7635532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide.
    Rudichenko VM; Beierwaltes WH
    J Vasc Res; 1995; 32(2):100-5. PubMed ID: 7734655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites.
    Cristol JP; Thiemermann C; Mitchell JA; Walder C; Vane JR
    Br J Pharmacol; 1993 May; 109(1):188-94. PubMed ID: 7684301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics.
    Deng X; Welch WJ; Wilcox CS
    Hypertension; 1996 May; 27(5):1173-9. PubMed ID: 8621213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats.
    Thompson A; Valeri CR; Lieberthal W
    Am J Physiol; 1995 Aug; 269(2 Pt 2):H743-8. PubMed ID: 7653640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
    Danielson LA; Conrad KP
    J Clin Invest; 1995 Jul; 96(1):482-90. PubMed ID: 7542284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure natriuresis in rats during blockade of the L-arginine/nitric oxide pathway.
    Johnson RA; Freeman RH
    Hypertension; 1992 Apr; 19(4):333-8. PubMed ID: 1313394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
    Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L
    Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal vascular and tubular actions of calcitonin gene-related peptide: effect of NG-nitro-L-arginine methyl ester.
    Elhawary AM; Pang CC
    J Pharmacol Exp Ther; 1995 Apr; 273(1):56-63. PubMed ID: 7714812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
    Ribeiro MO; Antunes E; de Nucci G; Lovisolo SM; Zatz R
    Hypertension; 1992 Sep; 20(3):298-303. PubMed ID: 1516948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction.
    Griffin KA; Bidani AK; Ouyang J; Ellis V; Churchill M; Churchill PC
    Am J Physiol; 1993 Jun; 264(6 Pt 2):R1254-9. PubMed ID: 8322982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal nitric oxide and angiotensin II interaction in renovascular hypertension.
    Sigmon DH; Beierwaltes WH
    Hypertension; 1993 Aug; 22(2):237-42. PubMed ID: 8340159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NG-hydroxy-L-arginine prevents the haemodynamic effects of nitric oxide synthesis inhibition in the anaesthetized rat.
    Walder CE; Thiemermann C; Vane JR
    Br J Pharmacol; 1992 Oct; 107(2):476-80. PubMed ID: 1422593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide.
    Nakamura T; Alberola AM; Granger JP
    Hypertension; 1993 Jun; 21(6 Pt 2):956-60. PubMed ID: 8505106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of renal nitric oxide synthesis with NG-monomethyl-L-arginine and NG-nitro-L-arginine.
    Naess PA; Kirkebøen KA; Christensen G; Kiil F
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F939-42. PubMed ID: 1535755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide.
    Clària J; Jiménez W; Ros J; Asbert M; Castro A; Arroyo V; Rivera F; Rodés J
    Hepatology; 1992 Feb; 15(2):343-9. PubMed ID: 1735539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.